{"SPADE_N_15339": {"Sequence Information": {"Peptide Name": "Trichorzin HA-7", "Sequence": "XGAXXQVVXGLXPLXXQ", "Sequence Length": 17, "Biological Activity": ["Antiparasitic", "Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Trichoderma harzianum", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Leveraging Peptaibol Biosynthetic Promiscuity for Next-Generation Antiplasmodial Therapeutics.", "Pubmed ID": "33565879", "Reference": "J Nat Prod. 2021;84:503-517", "Author": "Lee JW, Collins JE, Wendt KL, Chakrabarti D, Cichewicz RH", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33565879"}], "SPADE ID": "SPADE_N_15339", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00498", "Similarity": 1.0, "Sequence": "SCDFPLGACTPFRDCKESCIKFKTRAGQTFFDGKCRPRDRPSVWTACFCCYYDSIGAQ"}, {"SPADE_ID": "SPADE_UN_10996", "Similarity": 1.0, "Sequence": "CGVGFREGTCGAQ"}, {"SPADE_ID": "SPADE_N_06862", "Similarity": 0.8, "Sequence": "GLPLCGETCVGGTCNTPGCSCGWPVCVRN"}], "Hemolytic Activity": "", "Target Organism": "Plasmodium falciparum Dd2(EC50=0.59±0.06µM),Human hepatocellular carcinoma HepG2(EC50=11.10±0.92µM)"}}}